Cargando…

Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations

This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.

Detalles Bibliográficos
Autores principales:	Haymart, Brian, Barnes, Geoffrey D., Kong, Xiaowen, Ali, Mona, Kline-Rogers, Eva, DeCamillo, Deborah, Kaatz, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284330/ https://www.ncbi.nlm.nih.gov/pubmed/35834255 http://dx.doi.org/10.1001/jamanetworkopen.2022.22089

Ejemplares similares

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022)

Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach
por: Dawson, Taylor, et al.
Publicado: (2020)

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
por: Joyce, Elizabeth, et al.
Publicado: (2022)

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation
por: Schaefer, Jordan K., et al.
Publicado: (2022)

AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
por: Puroll, Eric, et al.
Publicado: (2014)

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics
por: Barnes, Geoffrey D., et al.
Publicado: (2017)

Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes
por: Remer, Hallie B., et al.
Publicado: (2022)

Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin
por: Alnewais, Marwah E., et al.
Publicado: (2023)

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Out‐of‐range INR results lead to increased health‐care utilization in four large anticoagulation clinics
por: Barnes, Geoffrey D, et al.
Publicado: (2018)

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2018)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry
por: Sciria, Christopher T., et al.
Publicado: (2020)

Limited English Proficient Patients and Time Spent in Therapeutic Range in a Warfarin Anticoagulation Clinic
por: Rodriguez, Fátima, et al.
Publicado: (2013)

A factor VII-based method for the prediction of anticoagulant response to warfarin
por: Ooi, Qing-Xi, et al.
Publicado: (2018)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Graves' Disease and Treatment Effects on Warfarin Anticoagulation
por: Howard-Thompson, Amanda, et al.
Publicado: (2014)

Beyond warfarin: The advent of new oral anticoagulants
por: Laroia, Sandeep T, et al.
Publicado: (2015)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats
por: Zayed, Aref, et al.
Publicado: (2020)

Quality of anticoagulation with warfarin in rural Chhattisgarh, India
por: Chebrolu, Puja, et al.
Publicado: (2020)

The Effect of Switching From Warfarin to Novel Oral Anticoagulants on Patients’ Satisfaction and the Travel Burden in a Rural Setting
por: Khiralla, Samir, et al.
Publicado: (2022)

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
por: Jansson, M., et al.
Publicado: (2023)

Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
por: Srivastava, Ajay, et al.
Publicado: (2008)

Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic—Warfarin Treatment in COVID-19
por: Emren, Zeynep Yapan, et al.
Publicado: (2021)

Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed‐methods study
por: Barnes, Geoffrey D., et al.
Publicado: (2018)

Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary care
por: Guimarães, Patrícia O, et al.
Publicado: (2015)

Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients
por: Thomson, Benjamin KA, et al.
Publicado: (2011)

Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
por: Ashouri, Feras, et al.
Publicado: (2011)

Quality of Anticoagulation With Warfarin at a Tertiary Hospital in Botswana
por: Mwita, Julius C., et al.
Publicado: (2017)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
por: Stolz, Leonie, et al.
Publicado: (2017)

Effect of rifampicin on anticoagulation of warfarin: A case report
por: Hu, Ya-Ni, et al.
Publicado: (2021)

Dual Anticoagulation With Warfarin and Apixaban: A Case Report
por: Parker, Kristen, et al.
Publicado: (2022)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19
por: Vaughn, Valerie M., et al.
Publicado: (2021)

Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial
por: Singer, Daniel E., et al.
Publicado: (2013)

Safety and efficacy of direct oral anticoagulants in comparison with warfarin across different BMI ranges: A systematic review and meta-analysis
por: Almas, Talal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_faa4d4b1202ctnnu4abogp7p9r